(Q35781217)

10 August 2017

1 reference

title

Advances in cell therapy for renal failure (English)

1 reference

10 August 2017

H David Humes

1

1 reference

10 August 2017

Mark S Szczypka

series ordinal

2

1 reference

10 August 2017

publication date

1 April 2004

1 reference

10 August 2017

published in

Transplant Immunology

1 reference

10 August 2017

volume

12

1 reference

10 August 2017

issue

3-4

1 reference

10 August 2017

page(s)

219-227

1 reference

Cell-based therapies go live

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

7 January 2021

Regenerative medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Stem cells in tissue engineering.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Human ES cells: can you build a business around them?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Embryo and stem cell research in the United States: history and politics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Cell fusion is the principal source of bone-marrow-derived hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Transplanted bone marrow regenerates liver by cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Cell therapy in Parkinson's disease - stop or go?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Cell encapsulation: promise and progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Replacement of renal function in uremic animals with a tissue-engineered kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Polymeric system for dual growth factor delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

The American health care system. The End Stage Renal Disease Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Independent association between acute renal failure and mortality following cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Mortality and costs of acute renal failure associated with amphotericin B therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Immunologic function and survival in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Plasma aminothiol oxidation in chronic hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Tissue engineering of a bioartificial renal tubule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Sepsis: a new hypothesis for pathogenesis of the disease process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Mediators, mechanisms and mortality in major trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Serum Cytokine Levels in Human Septic Shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Impaired cellular immune function in patients with end-stage renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Hypovitaminosis D in Medical Inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2003.12.015

10.1016/J.TRIM.2003.12.015

7 January 2021

Identifiers

DOI

1 reference

10 August 2017

1 reference